William F. Koch, Ph.D., M.D. – Research & Publications

William F. Koch, Ph.D., M.D.

Official Research Page

Menu

McDermitt Consulting

William F. Koch

1964 – DR. WM. F. KOCH RESPONDS TO SPECIFIC POSITIONS HELD BY THE FDA TO JUSTIFY THEIR OPPOSITION TO INTERSTATE COMMERCE OF GLYOXYLIDE. FDA CORRESPONDENCE OF 1962, 1963. A 8 PG. INTRODUCTORY STATEMENT

Koch's Publications 1950-1967 /

1964 – DR. WM. F. KOCH RESPONDS TO SPECIFIC POSITIONS HELD BY THE FDA TO JUSTIFY THEIR OPPOSITION TO INTERSTATE COMMERCE OF GLYOXYLIDE. FDA CORRESPONDENCE OF 1962, 1963. A 8 PG. INTRODUCTORY STATEMENT Print PDF

1964 – DR. WM. F. KOCH RESPONDS TO SPECIFIC POSITIONS HELD BY THE FDA TO JUSTIFY THEIR OPPOSITION TO INTERSTATE COMMERCE OF GLYOXYLIDE. FDA CORRESPONDENCE OF 1962, 1963. A 8 PG. INTRODUCTORY STATEMENT Read More »

William F. Koch

1963 – LOGIC AND CLINICAL DEVELOPMENT BY KOCH EXPLAINS THE ACTIVATION OF THE FUNCTIONAL CARBONYL GROUP SYSTEM’S IMPACT ON A CELL’S OXIDATION PROCESS AND LEADS TO ITS INABILITY TO HAVE THE OXYGEN REQUIRED TO FORM THE PEROXIDE FREE RADICAL TO CONTINUE THE OXIDATION PROCESS

Koch's Publications 1950-1967 /

1963 – LOGIC AND CLINICAL DEVELOPMENT BY KOCH EXPLAINS THE ACTIVATION OF THE FUNCTIONAL CARBONYL GROUP SYSTEM’S IMPACT ON A CELL’S OXIDATION PROCESS AND LEADS TO ITS INABILITY TO HAVE THE OXYGEN REQUIRED TO FORM THE PEROXIDE FREE RADICAL TO CONTINUE THE OXIDATION PROCESS Print PDF

1963 – LOGIC AND CLINICAL DEVELOPMENT BY KOCH EXPLAINS THE ACTIVATION OF THE FUNCTIONAL CARBONYL GROUP SYSTEM’S IMPACT ON A CELL’S OXIDATION PROCESS AND LEADS TO ITS INABILITY TO HAVE THE OXYGEN REQUIRED TO FORM THE PEROXIDE FREE RADICAL TO CONTINUE THE OXIDATION PROCESS Read More »